Viking Therapeutics, Inc. - Common Stock —— 财务数据 (NASDAQ:VKTX) | MetaTrader

展开完整图表完整图表

新闻

Why Is Viking Therapeutics (VKTX) Up 3.2% Since Last Earnings Report?

LLY Stock Gains 4% to All-Time High: Is Obesity Access the Catalyst?

Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider

Can EU Label Expansions of NVO's GLP-1 Drugs Spur Sales Growth?

LLY Reports Third Phase III Win for Next-Generation Obesity Drug

Can Mounjaro, Zepbound & Foundayo Keep Fueling LLY's Growth Story?

This Hot Weight-Loss Drug Stock May Have a Surprise Challenger

Can Novo Nordisk Sustain Its GLP-1 Edge Amid Lilly's Growing Pressure?

Lilly Bets on Next-Generation Obesity Drugs to Stay Ahead

NVO Rallies 21% in a Month: How Should Investors Play the Stock?

LLY Stock Pops 16% After Beat-and-Raise Q1: Buy, Hold or Take Profits?

Lilly's Oral GLP-1 Pill Foundayo Starts Strong in Oral Obesity Market